Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Liebowitz

Showing results (141-150 of 228) with videos related to

Pageof 23
Sort By:
Journal of Clinical Psychopharmacology|December 1, 1993
Fluoxetine for hypochondriacal patients without major depressionB A Fallon, M R Liebowitz, E Salmán, et al.
Psychiatry Research|April 1, 1990
Cardiac left ventricular hypertrophy and chamber dilatation in panic disorder patients: implications for idiopathic dilated cardiomyopathyJ P Kahn, J M Gorman, D L King, et al.
Biological Psychiatry|November 1, 1990
High-dose carbon dioxide challenge test in anxiety disorder patientsJ M Gorman, L A Papp, J Martinez, et al.
Journal of Clinical Psychopharmacology|August 1, 1993
Buspirone in social phobiaF R Schneier, J B Saoud, R Campeas, et al.
Psychiatry Research|December 1, 1987
An objective marker of lactate-induced panicJ M Gorman, M Davies, R Steinman, et al.
The American Journal of Psychiatry|July 1, 1984
Response to hyperventilation in a group of patients with panic disorderJ M Gorman, J Askanazi, M R Liebowitz, et al.
Psychopharmacology Bulletin|January 1, 1984
Psychopharmacological dissection of nonendogenous depressionM R Liebowitz, F M Quitkin, J M Stewart, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1996
Specificity of neuropsychological impairment in obsessive-compulsive disorder: a comparison with social phobic and normal control subjectsL J Cohen, E Hollander, C M DeCaria, et al.
Psychological Medicine|April 27, 2010
Moderators and predictors of response to cognitive-behavioral therapy augmentation of pharmacotherapy in obsessive-compulsive disorderM J Maher, J D Huppert, H Chen, et al.
The American Journal of Psychiatry|August 1, 1987
CO2 challenge of patients with panic disorderM R Fyer, J Uy, J Martinez, et al.
Pageof 23

Showing results (141-150 of 228) with videos related to

Sort By:
Pageof 23
Journal of Clinical Psychopharmacology|December 1, 1993
Fluoxetine for hypochondriacal patients without major depressionB A Fallon, M R Liebowitz, E Salmán, et al.
Psychiatry Research|April 1, 1990
Cardiac left ventricular hypertrophy and chamber dilatation in panic disorder patients: implications for idiopathic dilated cardiomyopathyJ P Kahn, J M Gorman, D L King, et al.
Biological Psychiatry|November 1, 1990
High-dose carbon dioxide challenge test in anxiety disorder patientsJ M Gorman, L A Papp, J Martinez, et al.
Journal of Clinical Psychopharmacology|August 1, 1993
Buspirone in social phobiaF R Schneier, J B Saoud, R Campeas, et al.
Psychiatry Research|December 1, 1987
An objective marker of lactate-induced panicJ M Gorman, M Davies, R Steinman, et al.
The American Journal of Psychiatry|July 1, 1984
Response to hyperventilation in a group of patients with panic disorderJ M Gorman, J Askanazi, M R Liebowitz, et al.
Psychopharmacology Bulletin|January 1, 1984
Psychopharmacological dissection of nonendogenous depressionM R Liebowitz, F M Quitkin, J M Stewart, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1996
Specificity of neuropsychological impairment in obsessive-compulsive disorder: a comparison with social phobic and normal control subjectsL J Cohen, E Hollander, C M DeCaria, et al.
Psychological Medicine|April 27, 2010
Moderators and predictors of response to cognitive-behavioral therapy augmentation of pharmacotherapy in obsessive-compulsive disorderM J Maher, J D Huppert, H Chen, et al.
The American Journal of Psychiatry|August 1, 1987
CO2 challenge of patients with panic disorderM R Fyer, J Uy, J Martinez, et al.
Pageof 23